Pliant Therapeutics (PLRX) Accumulated Depreciation & Amortization (2019 - 2025)
Historic Accumulated Depreciation & Amortization for Pliant Therapeutics (PLRX) over the last 7 years, with Q3 2025 value amounting to $12.0 million.
- Pliant Therapeutics' Accumulated Depreciation & Amortization rose 1629.3% to $12.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.0 million, marking a year-over-year increase of 1629.3%. This contributed to the annual value of $10.8 million for FY2024, which is 2447.59% up from last year.
- As of Q3 2025, Pliant Therapeutics' Accumulated Depreciation & Amortization stood at $12.0 million, which was up 1629.3% from $11.7 million recorded in Q2 2025.
- In the past 5 years, Pliant Therapeutics' Accumulated Depreciation & Amortization registered a high of $12.0 million during Q3 2025, and its lowest value of $3.8 million during Q1 2021.
- Its 5-year average for Accumulated Depreciation & Amortization is $7.9 million, with a median of $7.8 million in 2023.
- As far as peak fluctuations go, Pliant Therapeutics' Accumulated Depreciation & Amortization soared by 4952.14% in 2021, and later skyrocketed by 1629.3% in 2025.
- Over the past 5 years, Pliant Therapeutics' Accumulated Depreciation & Amortization (Quarter) stood at $5.0 million in 2021, then skyrocketed by 36.3% to $6.8 million in 2022, then rose by 26.91% to $8.7 million in 2023, then grew by 24.48% to $10.8 million in 2024, then increased by 11.35% to $12.0 million in 2025.
- Its Accumulated Depreciation & Amortization stands at $12.0 million for Q3 2025, versus $11.7 million for Q2 2025 and $11.3 million for Q1 2025.